Featuring perspectives from Prof John Seymour and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics:
Case: A woman in her mid 50s with multiple sclerosis, hypertension, IGHV-unmutated chronic lymphocytic leukemia (CLL) with an SF3B1 mutation a…
Featuring perspectives from Dr Matthew Matasar and Dr Sonali M Smith, including the following topics:
Introduction: Lymphoma Survivorship (0:00)
Novel Treatment Approaches for Diffuse Large B-Cell Lymphoma — Dr Matasar (6:49)
Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymph…
Featuring perspectives from Dr Amrita Krishnan and Dr Robert Z Orlowski, including the following topics:
Introduction (00:00)
Up-Front Progression-Free Survival for Standard-Risk Disease — 2006, 2016 (1:47)
Current and Emerging Therapeutic Approaches — Dr Orlowski (10:34)
Chimeric Antigen Receptor…
Featuring perspectives from Prof John Seymour, including the following topics:
Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
First-line treatment with sonrotocl…
Featuring perspectives from Dr William G Wierda, including the following topics:
Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00)
Sequencing Road Map (12:39)
Key Datasets — Pirtobrutinib (21:08)
Investigator Survey (34:09)
Chimeric Antigen Receptor T-Cell T…